Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2022 · 10-Q
Revenue$11.96M$11.96M+0.0% vs Q2 2021 Net Income-$4.23M-$4.23MN/M vs Q2 2021 EPS Diluted-$0.22-$0.22N/M vs Q2 2021 Gross Profit$2,847,000+7.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived$765,000N/M Free Cash Flowderived$762,000— Margins · derivedGross margin23.8%+1.6 pt vs Q2 2021
Operating margin-35.3%+19.0 pt vs Q2 2021
Net margin-35.3%+20.6 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end